Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Fms-related tyrosine kinase 3 ligand (FLT3LG) is a cytokine protein that acts as a growth factor, playing a crucial role in hematopoiesis, particularly in the proliferation and differentiation of blood cell progenitors. It stimulates the development, expansion, and mobilization of dendritic cells and increases immune cell numbers. FLT3LG exerts its effects by binding to its receptor, FMS-like tyrosine kinase 3 (FLT3/CD135), which leads to receptor activation and downstream signaling.
Binds and activates FMS-like tyrosine kinase 3 (FLT3/CD135) receptor, leading to receptor dimerization and autophosphorylation, triggering downstream signaling pathways.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Fms-related tyrosine kinase 3 ligand (FLT3LG).